Amgen first to win EU backing for new kind of cholesterol drug
May 22, 2015 at 07:23 AM EDT
May 22 (Reuters) - Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.
